A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia

Blood

Volumn 125, Issue 14, 2015, Pages 2265-2275

  Guida, Claudia ^a,b   Altamura, Sandro ^a,c   Klein, Felix A ^b   Galy, Bruno ^b   Boutros, Michael ^a   Ulmer, Artur J ^d   Hentze, Matthias W ^b,c   Muckenthaler, Martina U ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c Molecular Medicine Partnership Unit   (Germany)

^d RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN; HEPCIDIN; IRON; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; ANTIINFECTIVE AGENT; CATION TRANSPORT PROTEIN; LIPOPEPTIDE; METAL TRANSPORTING PROTEIN 1; PAM(3)CSK(4) PEPTIDE; TLR2 PROTEIN, MOUSE; TLR6 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATORY HYPOFERREMIA; INNATE IMMUNITY; IRON BLOOD LEVEL; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; ACUTE DISEASE; AGONISTS; ANIMAL; C57BL MOUSE; CELL CULTURE; DEFICIENCY; GENETICS; HELA CELL LINE; INFLAMMATION; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACUTE DISEASE; ANIMALS; ANTI-INFECTIVE AGENTS; BLOTTING, WESTERN; CATION TRANSPORT PROTEINS; CELLS, CULTURED; HELA CELLS; HEPCIDINS; HUMANS; INFLAMMATION; IRON; LIPOPEPTIDES; MALE; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6;

EID: 84926660351     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-08-595256     Document Type: Article

References (50)

1. Ward RJ, Crichton RR, Taylor DL, Della Corte L, Srai SK, Dexter DT. Iron and the immune system. J Neural Transm. 2011;118(3):315-328.
2. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta. 2009;1790(7): 682-693.
3. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20: 197-216.
4. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102(3):783-788.
5. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101(7): 2461-2463.
6. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood. 2005;106(5):1864-1866.
7. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9): 1271-1276.
8. Rodriguez R, Jung CL, Gabayan V, et al. Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infect Immun. 2014;82(2):745-752.
9. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090-2093.
10. Yang F, Liu XB, Quinones M, Melby PC, Ghio A, Haile DJ. Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J Biol Chem. 2002;277(42):39786-39791.
11. Liu XB, Nguyen NB, Marquess KD, Yang F, Haile DJ. Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. Blood Cells Mol Dis. 2005;35(1): 47-56.
12. Roy CN, Mak HH, Akpan I, Losyev G, Zurakowski D, Andrews NC. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood. 2007;109(9):4038-4044.
13. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA. 2002;99(7):4596-4601.
14. Rivera S, Liu L, Nemeth E, Gabayan V, Sorensen OE, Ganz T. Hepcidin excess induces the sequestration of iron and exacerbates tumorassociated anemia. Blood. 2005;105(4): 1797-1802.
15. Altamura S, Kessler R, Gröne HJ, et al. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload. Cell Metab. 2014;20(2):359-367.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402-408.
17. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA. 2000;97(25):13766-13771.
18. Okusawa T, Fujita M, Nakamura J, et al. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6. Infect Immun. 2004;72(3):1657-1665.
19. Farhat K, Riekenberg S, Heine H, et al. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukocyte Biol. 2008; 83(3):692-701.
20. Won K, Kim SM, Lee SA, Rhim BY, Eo SK, Kim K. Multiple signaling molecules are involved in expression of CCL2 and IL-1b in response to FSL-1, a Toll-like receptor 6 agonist, in macrophages. Korean J Physiol Pharmacol. 2012;16(6):447-453.
21. Peyssonnaux C, Zinkernagel AS, Datta V, Lauth X, Johnson RS, Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood. 2006; 107(9):3727-3732.
22. Buwitt-Beckmann U, Heine H, Wiesmüller KH, et al. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem. 2006;281(14): 9049-9057.
23. Deschemin JC, Vaulont S. Role of hepcidin in the setting of hypoferremia during acute inflammation. PLoS ONE. 2013;8(4):e61050.
24. Koening CL, Miller JC, Nelson JM, et al. Toll-like receptors mediate induction of hepcidin in mice infected with Borrelia burgdorferi. Blood. 2009; 114(9):1913-1918.
25. Layoun A, Huang H, Calvé A, Santos MM. Tolllike receptor signal adaptor protein MyD88 is required for sustained endotoxin-induced acute hypoferremic response in mice. Am J Pathol. 2012;180(6):2340-2350.
26. Ben-Othman R, Flannery AR, Miguel DC, Ward DM, Kaplan J, Andrews NW. Leishmania-mediated inhibition of iron export promotes parasite replication in macrophages. PLoS Pathog. 2014;10(1):e1003901.
27. Zumerle S, Mathieu JR, Delga S, et al. Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype. Blood. 2014; 123(23):3646-3650.
28. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J Leukocyte Biol. 2007;82(4): 934-945.
29. Theurl I, Theurl M, Seifert M, et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood. 2008;111(4): 2392-2399.
30. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol. 2003;15(1):5-11.
31. Buwitt-Beckmann U, Heine H, Wiesmüller KH, et al. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur J Immunol. 2005; 35(1):282-289.
32. Roy CN, Custodio AO, de Graaf J, et al. An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice. Nat Genet. 2004;36(5): 481-485.
33. Keck S, Freudenberg M, Huber M. Activation of murine macrophages via TLR2 and TLR4 is negatively regulated by a Lyn/PI3K module and promoted by SHIP1. J Immunol. 2010;184(10): 5809-5818.
34. Funayama H, Huang L, Asada Y, Endo Y, Takada H. Enhanced induction of a histamineforming enzyme, histidine decarboxylase, in mice primed with NOD1 or NOD2 ligand in response to various Toll-like receptor agonists. Innate Immun. 2010;16(4):265-272.
35. Du X, Fleiss B, Li H, et al. Systemic stimulation of TLR2 impairs neonatal mouse brain development. PLoS ONE. 2011;6(5):e19583.
36. Dietrich N, Lienenklaus S, Weiss S, Gekara NO. Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PLoS ONE. 2010;5(4):e10250.
37. De Luca K, Frances-Duvert V, Asensio MJ, et al. The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia. 2009;23(11): 2063-2074.
38. Hurley JC. Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev. 1995; 8(2):268-292.
39. Hurley JC. Concordance of endotoxemia with gram-negative bacteremia in patients with gramnegative sepsis: a meta-analysis. J Clin Microbiol. 1994;32(9):2120-2127.
40. Gnauck A, Lentle RG, Kruger MC. The Limulus Amebocyte Lysate assay may be unsuitable for detecting endotoxin in blood of healthy female subjects [published online ahead of print November 26, 2014]. J Immunol Methods.
41. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34(5):637-650.
42. Weiss DS, Raupach B, Takeda K, Akira S, Zychlinsky A. Toll-like receptors are temporally involved in host defense. J Immunol. 2004;172(7): 4463-4469.
43. Krutzik SR, Ochoa MT, Sieling PA, et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med. 2003;9(5): 525-532.
44. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gramnegative and gram-positive bacterial cell wall components. Immunity. 1999;11(4):443-451.
45. Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol. 2000;165(10):5392-5396.
46. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol. 2004;5(10):975-979.
47. Blankley S, Graham CM, Howes A, et al. Identification of the key differential transcriptional responses of human whole blood following TLR2 or TLR4 ligation in-vitro. PLoS ONE. 2014;9(5): e97702.
48. Elkon R, Linhart C, Halperin Y, Shiloh Y, Shamir R. Functional genomic delineation of TLR-induced transcriptional networks. BMC Genomics. 2007; 8:394.
49. Rodrigues PN, Gomes SS, Neves JV, et al. Mycobacteria-induced anaemia revisited: a molecular approach reveals the involvement of NRAMP1 and lipocalin-2, but not of hepcidin. Immunobiology. 2011;216(10):1127-1134.
50. Laftah AH, Sharma N, Brookes MJ, et al. Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice. Biochem J. 2006;397(1):61-67.